The technology is intended to treat distal radius fractures. It has received approval from the U.S. Food and Drug Administration as well as received a CE Mark.
The credit facility is provided by Oxford Finance and Square 1 Bank.
Conventus is a medical device company focused on creating less invasive solutions to treat a broad range of challenging peri-articular fractures.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
